https://www.selleckchem.com/pr....oducts/cirtuvivint.h
The aim of the study was to determine whether adjunctive hydrocortisone reduced healthcare expenditure and was cost-effective compared with placebo in New Zealand patients in the Adjunctive Glucocorticoid Therapy in Patients with Septic Shock (ADRENAL) trial. This is a health economic analysis using data linkage to New Zealand Ministry of Health databases to determine resource use, costs, and cost-effectiveness for a 24-month period. The study was conducted in New Zealand. Patients with septic shock were randomised to receive a 7-da
Aimer
Commentaire
Partagez
